Suzhou Highfine Biotech Co., Ltd.(stock code: 301393), established in 2003, is headquartered in Suzhou High-tech Zone It is a high-tech enterprise in Jiangsu province and provides characteristic chemicals for global pharmaceutical R&D and API production companies. our products are mainly used in the fields of peptide, nucleotide and pharmaceutical synthesis. At present, more than 1500 kinds of products have been developed and produced.


Over the years, Highfine Biotech has adhered to the principle of "continuous innovation and customer satisfaction", and is committed to serving the front-end process of new drug research and development, providing fast and accurate supporting services for innovative drug research and development and drug production. By keeping up with the research and development direction of global innovative drugs and meeting the market demands of CRO and CDMO companies at home and abroad, it has become a leading supplier of specialty functional chemicals in the industry.


Since 2003



Number of customers served



Types of R&D products


Area of R&D Center 


Facing the growing demands of the international pharmaceuticals,Highfine takes R&D and innovation as the first task with the aim of catering to customer needs.We will comprehensively construct the company’s core competitiveness and do our best to ensure production safety and environmental protection,further contribute to the society with professional chemical technology and excellent management system.Based on professional chemical technology and good management system.We strive to become an excellent company with sustainable growth,and we encourage innovation and embrace challenges.

Accurate and efficient

Helping the development of the global pharmaceutical industry

Pragmatic and honest

Innovation and win-win

Taking development and innovation

as the first task

Focus on customer needs



On December 2, 2003, Suzhou Highfine Biotech was formally established

In October 2007, the company was identified as a national high-tech enterprise

In February 2015, the company's headquarters moved to No. 32, Hongxi Road, Suzhou High-tech Zone

In January 2016, it was restructured into a joint-stock company

On September 19, 2018, the wholly-owned subsidiary Anhui Highfine Biotech Co., Ltd was established

The first phase of the Anhui factory was completed and put into operation. At the same time, the headquarters research institute was in construction.

Our Headquarters and Research Institute have been completed and put into use, and the second phase of the Anhui factory project is under construction. IPO and listed on Shenzhen Stock Exchange on July 12.


The board of directors and senior managers of the company are young and vigorous, with more than 50% of the team members having over 10 years of industry experience. Most of the team members have rich professional background in organic synthesis and in enterprise production and management.


We have long-term industry-university-research cooperation with Zhejiang University, Shanghai Jiaotong University, East China Normal University, Suzhou University and other universities, and at the same time hired a number of university experts and professors as technical consultants.


  • Enterprise Technology Center
  • National High-Tech Enterprise
  • Suzhou Engineering Technology Research Center
  • Jiangsu Postgraduate Workstation
  • Gazelle Enterprise in High-tech Zone
  • Private technology enterprise in Jiangsu Province
  • Science and Technology Entrepreneur of Jiangsu Province
  • Jiangsu Engineering Technology Research Center
  • Member of Peptide Branch
  • Provincial Engineering Technology Center
  • Advanced unit of scientific and technological innovation
  • Provincial Enterprise Technology Center
  • 2022年:苏州高新区专精特新中小企业,两化融合管理体系评定证书
    Specializing in new small and medium-sized enterprises